1. Home
  2. ATRC

ATRC

AtriCure Inc.

Logo AtriCure Inc.

Health Care

Medical/Dental Instruments

Nasdaq

as 04-17-2024 4:00pm EST

$
-
-
.
-
-
+$
-
.
-
-
+
-
.
-
-
%

AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. The company also offers a variety of minimally invasive ablation devices and access tools to facilitate the growing trend in less invasive cardiac and thoracic surgery. Geographically, it generates a majority of its revenue from the United States.

Founded: 2000 Country:
United States
United States
Employees: N/A City: MASON
Market Cap: 1.2B IPO Year: 2005
Target Price: $51.20 AVG Volume (30 days): 698.3K
Analyst Decision: Strong Buy Number of Analysts: 5
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -0.66 EPS Growth: N/A
52 Week Low/High: $23.75 - $59.61 Next Earning Date: 05-01-2024
Revenue: $399,245,000 Revenue Growth: 20.84%
Revenue Growth (this year): 17.85% Revenue Growth (next year): 14.02%

Share on Social Networks: